Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | HTR2A | P28223 | 2/20 | 0.46 |
| ▸ | HRH1 | P35367 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.43 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.43 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11501575 | 0.93 | KMT2A (0.48) | TAAR1HTR2AHRH1CA12CA2 | |
| SCHEMBL11044440 | 0.92 | CA12 (0.50) | TAAR1HTR2AHRH1CA12CA2 | |
| SCHEMBL21448012 | 0.86 | HTR2A (0.50) | TAAR1HTR2AHRH1CA12CA2 | |
| SCHEMBL2467097 | 0.83 | TDP1 (0.46) | TAAR1HTR2AHRH1CA12CA2 | |
| SCHEMBL23504663 | 0.83 | CA12 (0.44) | TAAR1CA12CA2CA9MEN1 | |
| SCHEMBL11145951 | 0.82 | CA12 (0.47) | TAAR1CA12CA2CA9MEN1 | |
| SCHEMBL13645984 | 0.82 | SIGMAR1 (0.48) | TAAR1CA12CA2CA9MEN1 | |
| Hydrochloric Acid SCHEMBL28327279 | 0.81 | TDP1 (0.43) | TAAR1HTR2AHRH1CA12CA2 | |
| SCHEMBL17037834 | 0.80 | SIGMAR1 (0.52) | TAAR1CA12CA2CA9SIGMAR1 | |
| SCHEMBL11501576 | 0.80 | TAAR1 (0.50) | TAAR1HTR2AHRH1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030060658-A1 | Process for preparing sorbic acid by thermal cleavage | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2003-03-27 | — | — | US | claimed |
| US-20230174485-A1 | LIPOXYGENASE INHIBITORS | SRI INTERNATIONAL (US) | 2023-06-08 | — | — | US | disclosed |
| US-20230118462-A1 | Process for Making Sorbic Acid from Renewable Materials | NUTRINOVA NETHERLANDS B.V. (NL) | 2023-04-20 | — | — | US | disclosed |
| WO-2023059603-A2 | A PROCESS FOR MAKING SORBIC ACID FROM RENEWABLE MATERIALS | CELANESE INTERNATIONAL CORPORATION (US) | 2023-04-13 | — | — | WO | disclosed |
| US-11345711-B2 | 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones | Impact Therapeutics (Shanghai), Inc (CN) | 2022-05-31 | — | — | US | disclosed |
| US-20200385394-A1 | 8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES | Impact Therapeutics (Shanghai), Inc (CN) | 2020-12-10 | — | — | US | disclosed |
| US-10703759-B2 | 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones | IMPACT THERAPEUTICS, INC (CN) | 2020-07-07 | — | — | US | disclosed |
| US-20190308984-A1 | 8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES | Impact Therapeutics (Shanghai), Inc (CN) | 2019-10-10 | — | — | US | disclosed |
| US-9911931-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-9790499-B2 | Functionally-modified oligonucleotides and subunits thereof | SAREPTA THERAPEUTICS, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| EP-1325902-A1 | Process for the preparation of sorbic acid | Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) | 2003-07-09 | — | — | EP | disclosed |
| US-20030060658-A1 | Process for preparing sorbic acid by thermal cleavage | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2003-03-27 | — | — | US | disclosed |
| EP-1295860-A2 | Process for the preparation of sorbic acid by thermal decomposition | Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) | 2003-03-26 | — | — | EP | disclosed |
| US-4898941-A | Process for preparing diphenylalkene derivatives | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1990-02-06 | — | — | US | disclosed |
| US-4446039-A | Organic compositions containing hydroxy-aromatic compounds useful as additives for fuels and lubricants | THE LUBRIZOL CORPORATION (US) | 1984-05-01 | — | — | US | disclosed |
| US-4369310-A | PHOTOGRAPHIC DYES | CIBA-GEIGY LTD. (CH) | 1983-01-18 | — | — | US | disclosed |
| EP-0029412-A2 | Bleachable dyestuffs, process for their preparation and their use in photographic material | CIBA-GEIGY AG (CH) | 1981-05-27 | — | — | EP | disclosed |
| US-4147643-A | REACTION PRODUCT OF PHENOL, FORMALDEHYDE, AND A CHLORO-PHENOL MODIFIED POLYOLEFIN | THE LUBRIZOL CORPORATION (US) | 1979-04-03 | — | — | US | disclosed |
| US-4119622-A | Pyrazolonylazoaniline or aminonaphtyl compounds for copying processes | BASF AKTIENGESELLSCHAFT (DE) | 1978-10-10 | — | — | US | disclosed |
| US-4101541-A | DYES FOR POLYESTERS OR POLYPROPYLENE | CIBA-GEIGY CORPORATION (US) | 1978-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230118462-A1 | Process for Making Sorbic Acid from Renewable Materials | BCKDK, ALKBH3, MCCC2 | TAAR1 2608/4885HTR2A 3542/4885HRH1 1514/4885 |
| US-20190308984-A1 | 8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES | WEE1, WEE2, CCNE1 | TAAR1 3639/4885HTR2A 3985/4885HRH1 1197/4885 |
| US-11345711-B2 | 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones | WEE1, WEE2, CCNE1 | TAAR1 3639/4885HTR2A 3985/4885HRH1 1197/4885 |
| US-20230174485-A1 | LIPOXYGENASE INHIBITORS | ALOX15B, ALOX12, ALOX15 | TAAR1 2643/4885HTR2A 826/4885HRH1 2397/4885 |
| US-10703759-B2 | 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones | WEE1, WEE2, CCNE1 | TAAR1 3639/4885HTR2A 3985/4885HRH1 1197/4885 |
| US-20200385394-A1 | 8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES | WEE1, WEE2, CCNE1 | TAAR1 3639/4885HTR2A 3985/4885HRH1 1197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.